Alpha DNA Investment Management LLC Has $492,000 Stock Holdings in Itron, Inc. (NASDAQ:ITRI)

Alpha DNA Investment Management LLC trimmed its holdings in shares of Itron, Inc. (NASDAQ:ITRI) by 5.4% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,602 shares of the scientific and technical instruments company’s stock after selling 262 shares during the period. Alpha DNA Investment Management LLC’s holdings in Itron were worth $492,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently bought and sold shares of the company. Sculptor Capital LP acquired a new position in Itron during the second quarter valued at $5,255,000. Assenagon Asset Management S.A. grew its stake in Itron by 7.8% in the second quarter. Assenagon Asset Management S.A. now owns 268,379 shares of the scientific and technical instruments company’s stock valued at $26,559,000 after purchasing an additional 19,387 shares in the last quarter. Tidal Investments LLC purchased a new position in Itron in the first quarter valued at about $1,319,000. Skandinaviska Enskilda Banken AB publ grew its stake in Itron by 97.8% in the second quarter. Skandinaviska Enskilda Banken AB publ now owns 10,207 shares of the scientific and technical instruments company’s stock valued at $1,012,000 after purchasing an additional 5,047 shares in the last quarter. Finally, Driehaus Capital Management LLC purchased a new position in Itron in the second quarter valued at about $18,758,000. 96.19% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research analysts have commented on the company. Stephens restated an “equal weight” rating and issued a $110.00 target price on shares of Itron in a research note on Monday, August 5th. Roth Mkm boosted their target price on Itron from $125.00 to $130.00 and gave the company a “buy” rating in a research note on Friday, November 1st. Robert W. Baird boosted their target price on Itron from $123.00 to $132.00 and gave the company an “outperform” rating in a research note on Friday, November 1st. Janney Montgomery Scott initiated coverage on Itron in a research note on Friday, September 27th. They set a “buy” rating and a $131.00 price target for the company. Finally, Guggenheim upped their price target on Itron from $128.00 to $135.00 and gave the stock a “buy” rating in a research note on Wednesday, November 6th. Four equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $123.92.

Insider Buying and Selling

In related news, CEO Thomas Deitrich sold 37,500 shares of the firm’s stock in a transaction on Tuesday, October 1st. The stock was sold at an average price of $104.83, for a total transaction of $3,931,125.00. Following the sale, the chief executive officer now owns 205,276 shares of the company’s stock, valued at approximately $21,519,083.08. This trade represents a 15.45 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 1.45% of the stock is currently owned by company insiders.

Itron Price Performance

Shares of NASDAQ:ITRI opened at $118.93 on Monday. The business has a 50 day moving average price of $109.53 and a 200 day moving average price of $104.97. Itron, Inc. has a twelve month low of $65.42 and a twelve month high of $124.90. The company has a market cap of $5.36 billion, a price-to-earnings ratio of 24.37, a PEG ratio of 0.89 and a beta of 1.46. The company has a quick ratio of 2.83, a current ratio of 3.36 and a debt-to-equity ratio of 0.91.

Itron (NASDAQ:ITRI) last posted its quarterly earnings results on Thursday, October 31st. The scientific and technical instruments company reported $1.84 EPS for the quarter, beating the consensus estimate of $1.13 by $0.71. The firm had revenue of $615.46 million during the quarter, compared to analysts’ expectations of $596.41 million. Itron had a return on equity of 19.03% and a net margin of 9.37%. The company’s revenue for the quarter was up 9.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.98 EPS. Research analysts predict that Itron, Inc. will post 5.33 earnings per share for the current year.

About Itron

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.